Advanced Point‐of‐Care Testing Technologies for Human Acute Respiratory Virus Detection. Issue 1 (8th October 2021)

• Record Type: Journal Article
• Authors: Zhang, Zhaowei; Ma, Peng; Ahmed, Rajib; Wang, Jie; Akin, Demir; Soto, Fernando; Liu, Bi‐Feng; Li, Peiwu; Demirci, Utkan
• Is Part Of: Advanced materials. Volume 34:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-08
• Subjects: clinical test -- detection -- point‐of‐care test -- respiratory virus -- sensitivity; Materials -- Periodicals; Chemical vapor deposition -- Periodicals; 620.11
• DOI: 10.1002/adma.202103646
• Languages: English
• ISSNs: 0935-9648

Abstract

Abstract: The ever‐growing global threats to human life caused by the human acute respiratory virus (RV) infections have cost billions of lives, created a significant economic burden, and shaped society for centuries. The timely response to emerging RVs could save human lives and reduce the medical care burden. The development of RV detection technologies is essential for potentially preventing RV pandemic and epidemics. However, commonly used detection technologies lack sensitivity, specificity, and speed, thus often failing to provide the rapid turnaround times. To address this problem, new technologies are devised to address the performance inadequacies of the traditional methods. These emerging technologies offer improvements in convenience, speed, flexibility, and portability of point‐of‐care test (POCT). Herein, recent developments in POCT are comprehensively reviewed for eight typical acute respiratory viruses. This review discusses the challenges and opportunities of various recognition and detection strategies and discusses these according to their detection principles, including nucleic acid amplification, optical POCT, electrochemistry, lateral flow assays, microfluidics, enzyme‐linked immunosorbent assays, and microarrays. The importance of limits of detection, throughput, portability, and specificity when testing clinical samples in resource‐limited settings is emphasized. Finally, the evaluation of commercial POCT kits for both essential RV diagnosis and clinical‐oriented practices is included. Abstract : The advanced rapid point‐of‐care tests (POCTs), including nucleic acid amplification, optical POCTs, electrochemistry, lateral flow assay, microfluidics, ELISA, and microarray‐based platforms, act figuratively as the Great Wall to the widespread transmission of acute respiratory virus infections by enabling early and rapid detection of these pathogens, as is the case during the current pandemic.